In 2009, Congress gave the U.S. Food and Drug Administration (FDA) the authority to address the addictiveness of combustible tobacco products by setting product standards. Decades of research suggest that nicotine is the primary cause of tobacco
addiction and that reducing nicotine delivery might reduce the rate and/or prevalence of smoking and have a dramatic impact on public health. In response to this opportunity, we established the Center for the Evaluation of Nicotine in Cigarettes (CENIC), a multi-institutional center aimed at addressing the question: Would a product standard requiring very low nicotine levels reduce cigarette use and improve public health? This presentation will focus on recent clinical and preclinical data from CENIC that address the potential benefits and risks of reducing nicotine as a
regulatory approach.
- Donny Presentation2
